New Phase 1 Clinical Trial to Test Durvalumab in Pediatric Patients
August 19, 2016
In an innovative, first-in-pediatrics study, available only at Children’s Hospital Los Angeles (CHLA), researchers will be enrolling children between 1 and 18 years of age who have certain types of